Neuberger Berman Group
VKTX icon

Neuberger Berman Group’s Viking Therapeutics VKTX Stock Holding History

Neuberger Berman Group’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,393
Closed -$251K – 2123
2025
Q1 		$251K Buy
+10,393
New +$328K ﹤0.01% 1752
2024
Q3 		– Sell
-70,669
Closed -$3.75M – 1996
2024
Q2 		$3.75M Buy
70,669
+4,136
+6% +$271K ﹤0.01% 971
2024
Q1 		$5.46M Sell
66,533
-39,966
-38% -$1.78M ﹤0.01% 901
2023
Q4 		$1.98M Buy
106,499
+22,188
+26% +$290K ﹤0.01% 1110
2023
Q3 		$933K Buy
84,311
+1,490
+2% +$21.3K ﹤0.01% 1276
2023
Q2 		$1.34M Buy
+82,821
New +$1.74M ﹤0.01% 1174

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM